Back
Diebold Nixdorf Vs. Janux Therapeutics Industry Stock Comparison
Sell
20
DBD
Diebold Nixdorf
Last Price:
$42.10
Seasonality Move:
18.24%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Sell
20
Diebold Nixdorf (DBD)
is a Sell
Is Diebold Nixdorf a Buy, Sell or Hold?
-
The current Diebold Nixdorf [DBD] share price is $42.07. The Score for DBD is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
DBD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DBD Stock Price Chart
What is Diebold Nixdorf's stock price today?
-
The Diebold Nixdorf share price today is $42.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBD is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
DBD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.9 | Sell |
| Relative Strength Index (14 RSI): | 36.27 | Sell |
| Chaikin Money Flow: | 37276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.73 - 47.37) | Sell |
| Bollinger Bands (100): | (41.31 - 46.61) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 41.88 | Sell |
| Chaikin Money Flow: | -1994706 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.74 - 62.68) | Sell |
| Bollinger Bands (100): | (44.76 - 56.7) | Buy |
DBD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.64 | Sell |
| 20-day SMA: | 44.64 | Sell |
| 50-day SMA: | 44.8 | Sell |
| 200-day SMA: | 41.4 | Buy |
| 8-day EMA: | 42.77 | Sell |
| 20-day EMA: | 43.82 | Sell |
| 50-day EMA: | 44.37 | Sell |
| 200-day EMA: | 40.21 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.68 | Sell |
| 20-day SMA: | 56.78 | Sell |
| 50-day SMA: | 54.64 | Sell |
| 200-day SMA: | 47.7 | Buy |
| 8-day EMA: | 54.12 | Sell |
| 20-day EMA: | 55.17 | Sell |
| 50-day EMA: | 54.12 | Sell |
| 200-day EMA: | 45.19 | Buy |
Diebold Nixdorf Earnings Growth & DBD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.22 per share, and an increase next year of $0.74 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
Diebold Nixdorf Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||